Global top pharmaceutical companies based on R&D spending 2024

In 2024, Johnson & Johnson and Roche are each projected to spend about 10 billion U.S. dollars on pharmaceutical research and development. Other companies with high projected R&D expenditures are Novartis, Pfizer, and Bristol-Myers Squibb.

Expenditure per country

The United States is projected to spend between 625 and 655 billion U.S. dollars on medicine in 2023. Current expenditures, as well as future estimates for the United States, are significantly higher than those of other high-spending countries, such as China, Japan, and Germany. Japan, for example, is expected to spend between 89 and 93 billion U.S. dollars on pharmaceuticals that year.

Johnson & Johnson

Johnson & Johnson is a major pharmaceutical company, which had a total employee count of about 135 thousand people in 2018, headquartered in New Jersey, United States. The multinational company produces various pharmaceutical products, including Remicade, Zytiga, Imbruvica, and Darzalex. In 2018, Remicade was the Johnson & Johnson’s top drug, earning the company almost five and half billion U.S. dollars in revenue. However, Johnson & Johnson has also significant medical devices and consumer products divisions.

Global top 10 pharmaceutical companies based on projected R&D spending in 2024

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

June 2019

Region

Worldwide

Survey time period

as of May 2019

Supplementary notes

All values are projections.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 / Month *
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Eli Lilly"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.